Skip to main content

Raphael Pharmaceutical Inc.

corporate_fare Company Profile

Raphael Pharmaceutical Inc.

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.

Exchange: OTCSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed RAPH - Latest Insights

RAPH
Mar 31, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
9